Attached files

file filename
S-1 - FORM S-1 - YUMANITY THERAPEUTICS, INC.d918922ds1.htm
EX-4.3 - EX-4.3 - YUMANITY THERAPEUTICS, INC.d918922dex43.htm
EX-3.3 - EX-3.3 - YUMANITY THERAPEUTICS, INC.d918922dex33.htm
EX-10.3 - EX-10.3 - YUMANITY THERAPEUTICS, INC.d918922dex103.htm
EX-10.1 - EX-10.1 - YUMANITY THERAPEUTICS, INC.d918922dex101.htm
EX-10.2 - EX-10.2 - YUMANITY THERAPEUTICS, INC.d918922dex102.htm
EX-10.4 - EX-10.4 - YUMANITY THERAPEUTICS, INC.d918922dex104.htm
EX-23.1 - EX-23.1 - YUMANITY THERAPEUTICS, INC.d918922dex231.htm
EX-10.8 - EX-10.8 - YUMANITY THERAPEUTICS, INC.d918922dex108.htm
EX-99.1 - EX-99.1 - YUMANITY THERAPEUTICS, INC.d918922dex991.htm
EX-10.5 - EX-10.5 - YUMANITY THERAPEUTICS, INC.d918922dex105.htm
EX-10.7 - EX-10.7 - YUMANITY THERAPEUTICS, INC.d918922dex107.htm
EX-10.13 - EX-10.13 - YUMANITY THERAPEUTICS, INC.d918922dex1013.htm
EX-10.12 - EX-10.12 - YUMANITY THERAPEUTICS, INC.d918922dex1012.htm
EX-10.14 - EX-10.14 - YUMANITY THERAPEUTICS, INC.d918922dex1014.htm

Exhibit 99.2

Consent of Director Nominee

December 22, 2015

Proteostasis Therapeutics, Inc.

200 Technology Square, 4th Floor

Cambridge, Massachusetts 02139

Ladies and Gentlemen:

Pursuant to Rule 438 of Regulation C promulgated under the Securities Act of 1933, as amended, and in connection with the Registration Statement on Form S-1 (the “Registration Statement”) filed by Proteostasis Therapeutics, Inc. (the “Issuer”), I hereby consent to being named and described as a prospective member of the board of directors of the Issuer in the Registration Statement and any amendment or supplement thereto. I also consent to the filing of this consent as an exhibit to such Registration Statement and any amendment or supplement thereto. I confirm that I intend to join the board of directors of the Issuer effective as of the effectiveness of the Registration Statement.

/s/ Helen Boudreau                

Helen Boudreau